ALK — Alkaloid AD Skopje Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeMid CapNeutral

Annual balance sheet for Alkaloid AD Skopje, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	MAS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	335	497	287	468	373
Net Total Accounts Receivable
Net Total Receivables	2,859	2,749	3,018	3,463	4,007
Total Inventory
Prepaid Expenses
Total Current Assets	6,947	7,366	8,293	9,622	10,537
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,163	6,452	6,976	8,059	8,251
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	15,015	15,879	17,589	19,954	21,471
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,418	3,475	4,428	5,385	5,966
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	4,107	4,217	5,082	6,163	6,777
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	10,908	11,662	12,507	13,790	14,694
Total Liabilities & Shareholders' Equity	15,015	15,879	17,589	19,954	21,471
Total Common Shares Outstanding